BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006433:Hemocyanins; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology*; D007114:Immunization; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D008875:Middle Aged; D008974:Mollusca / Q000276:immunology; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000276:immunology* / Q000628:therapy; D012882:Skin Tests; D013997:Time Factors
D001500:BCG Vaccine; D007136:Immunoglobulins; D006433:Hemocyanins